Activatable fluorescent probes for real-time imaging-guided tumor therapy
Surgery and drug therapy are the two principal options for cancer treatment. However, their
clinical benefits are hindered by the difficulty of accurate location of the tumors and timely …
clinical benefits are hindered by the difficulty of accurate location of the tumors and timely …
Inflammatory processes in cardiovascular disease: a route to targeted therapies
Inflammatory processes are firmly established as central to the development and
complications of cardiovascular diseases. Elevated levels of inflammatory markers have …
complications of cardiovascular diseases. Elevated levels of inflammatory markers have …
In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications
A Refaat, ML Yap, G Pietersz, APG Walsh… - Journal of …, 2022 - Springer
Advances in diagnostic imaging have provided unprecedented opportunities to detect
diseases at early stages and with high reliability. Diagnostic imaging is also crucial to …
diseases at early stages and with high reliability. Diagnostic imaging is also crucial to …
Endoscopic optical coherence tomography: technologies and clinical applications
In this paper, we review the current state of technology development and clinical
applications of endoscopic optical coherence tomography (OCT). Key design and …
applications of endoscopic optical coherence tomography (OCT). Key design and …
[HTML][HTML] Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment
Atherosclerosis, a chronic cardiovascular disease caused by plaque development in
arteries, remains a leading cause of morbidity and mortality. Atherosclerotic plaques are …
arteries, remains a leading cause of morbidity and mortality. Atherosclerotic plaques are …
Coronary atherosclerotic vulnerable plaque: current perspectives
C Stefanadis, CK Antoniou, D Tsiachris… - Journal of the American …, 2017 - Am Heart Assoc
Atherosclerosis is the most common form of vascular disease and constitutes the major
cause of death, with 17.5 million related deaths annually (31% of global mortality). 1 …
cause of death, with 17.5 million related deaths annually (31% of global mortality). 1 …
Nanotechnology for cardiovascular diseases
Q Hu, Z Fang, J Ge, H Li - The Innovation, 2022 - cell.com
Cardiovascular diseases have become the major killers in today's world, among which
coronary artery diseases (CADs) make the greatest contributions to morbidity and mortality …
coronary artery diseases (CADs) make the greatest contributions to morbidity and mortality …
[HTML][HTML] Intracoronary optical coherence tomography: state of the art and future directions: State of the art in OCT
Optical coherence tomography (OCT) has been increasingly utilised to guide percutaneous
coronary intervention (PCI). Despite the diagnostic utility of OCT, facilitated by its high …
coronary intervention (PCI). Despite the diagnostic utility of OCT, facilitated by its high …
Myocardial infarction—From atherosclerosis to thrombosis: Uncovering new diagnostic and therapeutic approaches
J Palasubramaniam, X Wang… - … , thrombosis, and vascular …, 2019 - Am Heart Assoc
One of the earliest and best-recognized elements of atherosclerosis is its close relationship
with circulating LDL (low-density lipoprotein). There is convincing evidence that LDL …
with circulating LDL (low-density lipoprotein). There is convincing evidence that LDL …
Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis–novel insights and future directions in diagnosis and therapy
We provide an up-to-date overview of current topics surrounding oxidized low-density
lipoprotein (oxLDL) and its related antibodies in the quest to better identify the individuals at …
lipoprotein (oxLDL) and its related antibodies in the quest to better identify the individuals at …